Key facts
- XRlabs’s last known valuation is $10.9M (Feb 2025).
- It has raised $2.4M; the latest was Seed Round ($2.4M) in Feb 2025.
- Notable investors include Eka Ventures, Eric Johnson.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for XRlabs
- ·The full record, as it builds
Funding rounds
No funding rounds for XRlabs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About XRlabs
Developer of mixed reality technology intended to provide enhanced 3D surgical experiences. The company specializes in cutting-edge mixed reality simulations and platforms in complex surgical environments, elevates the detail in 3D models, fostering immersive learning experiences, enabling medical professionals to support surgical procedures ensuring that mixed reality becomes an integral part of modern surgical practice.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2024
- Employees
- 6
- Website
- xrlabs.ai/
- Ownership
- Privately Held (backing)
XRlabs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in XRlabs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on XRlabs in its N-PORT filings yet. We sweep new filings monthly.